![](https://www.prime-ckd.com/wp-content/uploads/2023/11/17528062-1508834610343.webp)
Clinical Translational Sci – 2023
A new publication by the PRIME-CKD team on precision medicine in regulatory decision making has seen the light. The study provides an in-depth review of the inclusion of biomarkers in clinical development programs of approved medicines in Europe.
Biomarkers are crucial for the advancement of precision medicine!